https://biotechmorning.com/news/fda-oncology-trial-eligibility-guidances-2026 Biotech Morning en 2026-08-02T14:22:47.501Z The FDA Just Blew Open the Doors to Cancer Clinical Trials https://biotechmorning.com/news/tepezza-lost-monopoly-viridian-lumvoa-approval Biotech Morning en 2026-08-02T14:22:02.546Z Tepezza Just Lost Its $1.9 Billion Monopoly https://biotechmorning.com/news/one-dose-lsd-beat-every-antidepressant Biotech Morning en 2026-08-02T14:21:05.985Z One Dose of LSD Just Beat Every Antidepressant on the Market https://biotechmorning.com/news/lilly-abbisko-china-oncology-deal Biotech Morning en 2026-08-02T14:20:14.082Z Lilly Just Bet $1.9B on a Shanghai Biotech. In This Political Climate. https://biotechmorning.com/news/lantheus-cancer-imaging-fda-manufacturing-rejection Biotech Morning en 2026-08-02T14:19:20.907Z Lantheus Built a Better Cancer Scanner. The Factory Couldn't Keep Up. https://biotechmorning.com/news/ebola-bundibugyo-strain-vaccine-race Biotech Morning en 2026-08-02T14:18:40.616Z The Ebola Strain Nobody Had a Vaccine For Just Became a Global Emergency https://biotechmorning.com/news/fda-shaved-year-off-drug-timeline Biotech Morning en 2026-08-02T14:17:52.796Z The FDA Just Shaved a Year Off Your Drug's Timeline https://biotechmorning.com/news/fda-real-time-clinical-trial-monitoring-pilot Biotech Morning en 2026-08-02T14:16:57.406Z The FDA Wants to Watch Your Clinical Trial Live. Yes, Really. https://biotechmorning.com/news/oruka-one-shot-psoriasis-beats-skyrizi Biotech Morning en 2026-08-02T14:16:05.237Z One Shot a Year: The Tiny Biotech That Just Embarrassed AbbVie's $18B Drug https://biotechmorning.com/news/intellia-crispr-phase-3-fda-filing Biotech Morning en 2026-08-02T14:15:13.846Z One Shot to Edit Your DNA Forever. The FDA Might Say Yes. https://biotechmorning.com/news/ipsen-two-acquisitions-one-week-rare-disease Biotech Morning en 2026-08-01T14:23:47.679Z Ipsen Just Spent $2.5 Billion in One Week. Here's What They're Chasing. https://biotechmorning.com/news/astrazeneca-cspc-kidney-disease-sirna-deal Biotech Morning en 2026-08-01T14:22:54.586Z AstraZeneca's $1.77B Bet on a Chinese Partner Nobody Expected https://biotechmorning.com/news/novo-inflammation-drug-trial-failure Biotech Morning en 2026-08-01T14:22:03.104Z Novo's Big Bet on Inflammation Just Went Up in Smoke https://biotechmorning.com/news/lilly-2-3-billion-ajax-jak-inhibitor-deal Biotech Morning en 2026-08-01T14:21:14.900Z Lilly Just Bet $2.3 Billion That a Failed Drug Class Deserves a Second Chance https://biotechmorning.com/news/legend-biotech-in-vivo-car-t-perfect-response-rate Biotech Morning en 2026-08-01T14:20:20.688Z Legend Biotech Just Went 6 for 6 With a CAR-T That Builds Itself https://biotechmorning.com/news/bms-15-billion-hengrui-china-deal Biotech Morning en 2026-08-01T14:19:27.039Z BMS Just Bet $15 Billion on China's Drug Pipeline https://biotechmorning.com/news/fda-precheck-manufacturing-pilot-fast-lane Biotech Morning en 2026-08-01T14:18:33.255Z The FDA Just Created a Secret Fast Lane for Drug Factories https://biotechmorning.com/news/pfizer-ritlecitinib-vitiligo-phase-3-results Biotech Morning en 2026-08-01T14:17:45.287Z Pfizer Just Found a Way to Bring Color Back https://biotechmorning.com/news/first-toddlers-eligible-crispr-gene-therapy Biotech Morning en 2026-08-01T14:16:54.868Z The First Toddlers Eligible for CRISPR Are Two Years Old https://biotechmorning.com/news/novartis-myricx-adc-acquisition Biotech Morning en 2026-08-01T14:16:00.968Z Novartis Just Paid $1.1 Billion for a Drug That's Never Been Tested in Humans